Condition
Locally Advanced or Metastatic Non-small Cell Lung Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Locally Advanced or Metastatic Non-small Cell Lung Cancer clinical trials that are recruiting, at sites in 20 countries (most in China (5), Australia (2), South Korea (2)). By phase: Phase 1 (2), Phase 2 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 20Countries
Newest Locally Advanced or Metastatic Non-small Cell Lung Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| SHR2554 combined with other cancer drugs for advanced non-small cell lung cancer | Phase 2 | Guangzhou, Guangdong | Recruiting | Sep 16, 2025 |
| Evaluating AST2303 Tablets in Patients with Advanced Lung Cancer | Phase 1 | Shanghai, Shanghai Municipality | Recruiting | May 2, 2025 |
| XZP-5955 tablets for patients with specific advanced solid tumors | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Aug 9, 2021 |
| Safety of T-DXd with Immunotherapy in Advanced HER2+ Lung Cancer | Phase 1 | Duarte, California and 90 other locations | Recruiting | Dec 28, 2020 |
| Evaluating PF-07248144 for advanced solid tumors | Phase 2 | Scottsdale, Arizona and 42 other locations | Recruiting | Oct 28, 2020 |
All recruiting trials (5)
-
SHR2554 combined with other cancer drugs for advanced non-small cell lung cancer
This study tests whether SHR2554 tablets given with other anti-cancer treatments are safe and can shrink tumors in adults with locally advanced or metastatic non-small cell lung cancer.
-
Evaluating AST2303 Tablets in Patients with Advanced Lung Cancer
This study is testing if AST2303 tablets are safe and effective for people with advanced non-small cell lung cancer.
-
XZP-5955 tablets for patients with specific advanced solid tumors
This study is testing if XZP-5955 tablets can help patients with advanced solid tumors that have specific gene changes, especially those who have run out of other treatment options.
-
Safety of T-DXd with Immunotherapy in Advanced HER2+ Lung Cancer
This study is testing if a new combination of a drug called T-DXd with immunotherapy and chemotherapy is safe for people with advanced HER2-positive lung cancer.
-
Evaluating PF-07248144 for advanced solid tumors
This study is testing a new drug called PF-07248144 to see if it can safely help people with advanced solid tumors, like certain types of breast, prostate, and lung cancers.
Related topics
Quick answers
How many Locally Advanced or Metastatic Non-small Cell Lung Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 20 countries. The most sites are in China (5 trials), Australia (2 trials), South Korea (2 trials), United States (2 trials), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.